Is Thymosin Alpha-1 Legal in Oregon?

  • Also known as / Thymalfasin, Ta1
  • FDA approval / None; no US application [1]
  • Foreign approvals / Italy, India, Hong Kong [1]
  • State-licensed pharmacy list / In none of the three categories [2]
  • Outsourcing facility list / Category 3, nominated without adequate support [3]
  • Advisory committee vote / 4 yes, 17 no, December 2024 [4]
  • WADA 2026 Prohibited List / Not named [5]

What thymosin alpha-1 is

Thymosin alpha-1 (thymalfasin, Ta1) is a 28-amino-acid peptide first isolated from thymosin fraction 5, a thymus extract; thymalfasin is the synthetic version with the same sequence [1]. Zadaxin is the brand of finished injection sold outside the US at 1.6 mg per vial and is not interchangeable with bulk Ta1 powder [1].

Is it FDA-approved?

No. A Drugs@FDA search found no US application for thymosin alpha-1 [1]. Four US orphan drug designations do not change that, because orphan designation is not an approval [1].

FDA lists national authorizations in Italy, where Zadaxin is an adjuvant to influenza vaccination in immunocompromised people, in India for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication, and in Hong Kong [1]. The European Medicines Agency has only an orphan designation, for hepatocellular carcinoma [1].

What FDA has said about compounding

Thymosin alpha-1 is in none of the three categories on FDA's list of bulk drug substances for state-licensed pharmacies and physicians (updated May 14, 2026) [2]. On the separate list for outsourcing facilities (updated March 21, 2025) it is in category 3, 'nominated without adequate support' [3].

FDA proposed not adding thymosin alpha-1 to the pharmacy bulks list. On December 4, 2024, its Pharmacy Compounding Advisory Committee voted 4 yes and 17 no, with no abstentions, on both the free base and the acetate [4].

FDA's page on bulk substances that may raise significant safety risks lists it in the 'nominated but withdrawn' table. It had been in category 2 and came off because the nominators withdrew [6]. FDA's posted concerns remain: immunogenicity for certain routes of administration, peptide impurities and characterization problems, and safety information inadequate for FDA to understand the extent of any safety issues [6].

Thymosin alpha-1 is also not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy (BPC-157, epitalon, KPV, MOTS-c, Semax, TB-500) [7].

Oregon

These are federal records. They do not state Oregon rules on possessing, selling or compounding thymosin alpha-1, so they cannot settle the Oregon question.

What the Italian label says

The Italian Zadaxin label says the product is not for children, is contraindicated in pregnancy and breastfeeding, and calls for caution in people with allergies or autoimmune disease and with other immune-modulating drugs [1].

FDA's search of its adverse-event database on April 22, 2024 found zero reports for the peptide [1]. Authors tied to the manufacturer report more than 4,400 trial enrollees and more than 17 million post-marketing doses, with adverse experiences 'infrequent and mild'; treat that as company-linked data [1].

Is thymosin alpha-1 legal in Oregon?
Federal records do not settle it. Thymosin alpha-1 is not FDA-approved [1], and it is in none of the three categories on FDA's list for state-licensed pharmacies and physicians [2]. Those records do not state Oregon rules.
Is thymosin alpha-1 FDA-approved?
No. A Drugs@FDA search found no US application for it [1]. Four US orphan drug designations do not change that, because orphan designation is not an approval [1].
Can a US compounding pharmacy make thymosin alpha-1?
FDA's list for state-licensed pharmacies does not include it in any of the three categories [2], and on the outsourcing-facility list it is category 3 [3]. FDA proposed not adding it, and the advisory committee voted 4 yes, 17 no [4].
Does WADA ban thymosin alpha-1?
It is not named on WADA's 2026 Prohibited List [5]. WADA does name thymosin-beta-4 and TB-500, which are different peptides [5].
Show all 7 referencesHide references
Evidence overview for Is Thymosin Alpha-1 Legal in Oregon?